# Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain

> **NCT04239976** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Chemotherapy-Induced Peripheral Neuropathy
- Malignant Neoplasm

## Interventions

- **DEVICE:** FitBit
- **OTHER:** Gait Assessment Test
- **OTHER:** MC5-A Scrambler Therapy
- **OTHER:** Quality-of-Life Assessment
- **PROCEDURE:** Quantitative Sensory Testing
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04239976
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-04
- **Primary completion:** 2022-03-18
- **Final completion:** 2022-03-18
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04239976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04239976, "Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04239976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*